Corporate Information
CEO Message
Mission
Corporate Information
Corporate Governance
Business
Stemrim History
About “Regeneration-Inducing Medicine
™
”
What is “Regeneration-Inducing Medicine
™
”?
Issues of Conventional Cell Therapy
The Superiority of “Regeneration-Inducing Medicine
™
”
Business
Areas of Disease and Pipeline
“Regeneration-Inducing Medicine
™
”
Autologous cell sampling devices for medical treatment
Stem cells gene therapy
Research Paper
Investor Relations
COO Message
Investor News
ESG
Financial Data
Investor Library
Investor Calendar
Analyst Coverage
Stock Prices
Investor Relations
Financial Reports
September 13, 2024
Presentation Materials Financial Results for the the Fiscal Year Ended July 31, 2024
March 15, 2024
Presentation Materials for Six Months Ended January 31, 2024
Click here for past list ら
StemRIM
>
Investor Relations
>
Investor Library
>
Financial Reports
